policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…
policy
Raw diets for dogs and cats
The AVMA discourages the feeding to cats and dogs of any animal-source protein that has not first been subjected to a process to eliminate pathogens…
policy
Therapeutic pet food health claims
The FDA uses enforcement discretion in overseeing certain pet food claims. While many of these could legally be considered drugs, certain claims are…
policy
Truthful and nonmisleading human food labeling
The AVMA supports truthful and non-misleading labeling of animal-derived human food products that meets specific criteria.
policy
Veterinary diagnostic laboratory funding
The AVMA encourages ongoing funding and support to develop and maintain monitoring, surveillance, and surge capacity within the Integrated Consortium…